Clinical trial
A Multiple Rising-Dose Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection
NCT00047814 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multiple Rising-Dose Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2002
- Completion date
- March 31, 2006
- Enrollment
- 48
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.